Clinical trial
Exenatide for Myocardial Protection During Reperfusion Study: A Double-blind, Placebo-controlled Trial
NCT01938235 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Exenatide for Myocardial Protection During Reperfusion Study: A Double-blind, Placebo-controlled Trial
- Lead sponsor
- University Health Network, Toronto
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- February 28, 2014
- Completion date
- January 31, 2018
- Enrollment
- 198 (estimated)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.